TRIDENT LIFELINE
Back to Balance Sheet
|
TRIDENT LIFELINE Last 5 Year Sundry Debtors History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|
| Sundry Debtors | ₹28 Cr | ₹13 Cr | ₹12 Cr | ₹4.97 Cr |
What is the latest Sundry Debtors ratio of TRIDENT LIFELINE ?
| Year | Sundry Debtors |
|---|---|
| Mar2025 | ₹28 Cr |
| Mar2024 | ₹13 Cr |
| Mar2023 | ₹12 Cr |
| Mar2022 | ₹4.97 Cr |
How is Sundry Debtors of TRIDENT LIFELINE Trending?
| Years | Sundry Debtors | % Change | |
|---|---|---|---|
| Mar2025 | ₹28 Cr | 105.93 | |
| Mar2024 | ₹13 Cr | 11.19 | |
| Mar2023 | ₹12 Cr | 143.46 | |
| Mar2022 | ₹4.97 Cr | - | |
Compare Sundry Debtors of peers of TRIDENT LIFELINE
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| TRIDENT LIFELINE | ₹363.0 Cr | 3.8% | 15.4% | 7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹441,958.0 Cr | -3% | -5.2% | 17.9% | Stock Analytics | |
| DIVIS LABORATORIES | ₹247,576.0 Cr | 0.2% | 9.7% | 56.1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹189,233.0 Cr | 1.3% | 2% | 36.5% | Stock Analytics | |
| CIPLA | ₹110,273.0 Cr | -2.2% | -6.6% | -10.5% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹96,906.4 Cr | 1.4% | -3.7% | -8.8% | Stock Analytics | |
TRIDENT LIFELINE Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| TRIDENT LIFELINE | 3.8% |
15.4% |
7% |
| SENSEX | -2.3% |
-4.1% |
-7.4% |
You may also like the below Video Courses